Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1989 2
1990 2
1994 1
1995 1
1996 2
1997 4
1998 3
1999 1
2000 1
2001 3
2002 2
2003 3
2004 3
2005 2
2006 4
2007 5
2008 16
2009 7
2010 8
2011 7
2012 12
2013 7
2014 10
2015 12
2016 9
2017 8
2018 7
2019 7
2020 8
2021 6
2022 4
2023 5
2024 8
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S, Bay J, Franz AR, Ehrhardt H, Klein L, Petzinger J, Binder C, Kirschenhofer S, Stein A, Hüning B, Heep A, Cloppenburg E, Muyimbwa J, Ott T, Sandkötter J, Teig N, Wiegand S, Schroth M, Kick A, Wurm D, Gebauer C, Linnemann K, Kittel J, Wieg C, Kiechl-Kohlendorfer U, Schmidt S, Böttger R, Thomas W, Brevis Nunez F, Stockmann A, Kriebel T, Müller A, Klotz D, Morhart P, Nohr D, Biesalski HK, Giannopoulou EZ, Hilt S, Poryo M, Wagenpfeil S, Haiden N, Ruckes C, Ehrlich A, Gortner L; NeoVitaA trial investigators. Meyer S, et al. Lancet Respir Med. 2024 Jul;12(7):544-555. doi: 10.1016/S2213-2600(24)00073-0. Epub 2024 Apr 18. Lancet Respir Med. 2024. PMID: 38643780 Clinical Trial.
Three-dimensional tissue engineered skeletal muscle modelling facioscapulohumeral muscular dystrophy.
Franken M, van der Wal E, Zheng D, den Hamer B, van der Vliet PJ, Lemmers RJLF, van den Heuvel A, Dorn AL, Duivenvoorden CGA, In 't Groen SLM, Freund C, Eussen B, Tawil R, van Engelen BGM, Pijnappel WWMP, van der Maarel SM, de Greef JC. Franken M, et al. Among authors: van den heuvel a. Brain. 2025 May 13;148(5):1723-1739. doi: 10.1093/brain/awae379. Brain. 2025. PMID: 39556762 Free PMC article.
Left ventricular restoration devices post myocardial infarction.
Hendriks T, Schurer RAJ, Al Ali L, van den Heuvel AFM, van der Harst P. Hendriks T, et al. Among authors: van den heuvel afm. Heart Fail Rev. 2018 Nov;23(6):871-883. doi: 10.1007/s10741-018-9711-2. Heart Fail Rev. 2018. PMID: 29770903 Free PMC article. Review.
snRNA-seq analysis in multinucleated myogenic FSHD cells identifies heterogeneous FSHD transcriptome signatures associated with embryonic-like program activation and oxidative stress-induced apoptosis.
Zheng D, Wondergem A, Kloet S, Willemsen I, Balog J, Tapscott SJ, Mahfouz A, van den Heuvel A, van der Maarel SM. Zheng D, et al. Among authors: van den heuvel a. Hum Mol Genet. 2024 Jan 20;33(3):284-298. doi: 10.1093/hmg/ddad186. Hum Mol Genet. 2024. PMID: 37934801 Free PMC article.
Long-range gene regulation and novel therapeutic applications.
van den Heuvel A, Stadhouders R, Andrieu-Soler C, Grosveld F, Soler E. van den Heuvel A, et al. Blood. 2015 Mar 5;125(10):1521-5. doi: 10.1182/blood-2014-11-567925. Epub 2015 Jan 23. Blood. 2015. PMID: 25617428 Free article. Review.
Multiscale 3D-printing of microfluidic AFM cantilevers.
Kramer RCLN, Verlinden EJ, Angeloni L, van den Heuvel A, Fratila-Apachitei LE, van der Maarel SM, Ghatkesar MK. Kramer RCLN, et al. Among authors: van den heuvel a. Lab Chip. 2020 Jan 21;20(2):311-319. doi: 10.1039/c9lc00668k. Epub 2019 Dec 6. Lab Chip. 2020. PMID: 31808485
174 results